Financials

  • Market Capitalization 2.44 M
  • Employee 3
  • Founded 1996
  • CEO N/A
  • Website www.oragenics.com
  • Headquarter Florida, United States
  • FIGI BBG000PTF8K2
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.17
Price to sales ratio
-128.05

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
5032
MTNB
Matinas Biopharma Holdings, Inc. Common Stock
0.20 USD0.00%+11.11%-23.08%-67.75%2.94 M USD
5051
ONCO
Onconetix, Inc. - Common Stock
0.63 USD-1.56%-3.08%-22.22%-17.11%2.49 M USD
5054
SPRC
SciSparc Ltd. - Ordinary Shares
6.62 USD-1.78%+1.85%+5.25%+134.75%2.42 M USD
5066
SLXN
Silexion Therapeutics Corp - Ordinary Shares
0.36 USD+2.86%-7.69%-82.61%-77.64%2.00 M USD

Frequently asked questions about Oragenics Inc.

What is the Oragenics Inc. stock price today?

The current price of Oragenics Inc. (OGEN) is 0.54. Over the past 24 hours, the stock has changed by 0.00%. Follow the OGEN chart for real-time price dynamics.

What is the stock ticker of Oragenics Inc.?

Oragenics Inc. trades under the ticker OGEN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Oragenics Inc. stock going up?

OGEN has changed by 0.00% over the last week, +8.00% over the last month, and -14.76% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Oragenics Inc.?

Oragenics Inc. currently has a market capitalization of 2.44 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Oragenics Inc. earnings last quarter?

Last quarter, Oragenics Inc. reported earnings of -0.57 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Oragenics Inc. revenue for the last quarter?

Oragenics Inc. reported quarterly revenue of -12.17 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Oragenics Inc. net income for the last quarter?

Oragenics Inc. reported net income of -2.53 M for the last quarter. The previous quarter showed -2.2 M, which means net income changed by -14.88%.

How many employees does Oragenics Inc. have?

As of the latest available data, Oragenics Inc. has 3 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Oragenics Inc. stock?

You can buy Oragenics Inc. (OGEN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Oragenics Inc. stock?

Investing in Oragenics Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the OGEN chart and related analysis on metatrader.com as part of your research.

News